Abiopharma

SmartVest - Electromed, Inc. Announces Fiscal 2025 Third Quarter Results

Allurion - Allurion Presents Data on the Allurion Balloon and AI-Powered Virtual Care Suite with and without GLP-1s to Optimize Muscle Mass and Increase Weight Loss

New Form ARS - HEALTHEQUITY, INC. Filed: 2025-05-13 AccNo: 0001428336-25-000018 Size: 24 MB

New Form 8-K - Gevo, Inc. Filed: 2025-05-13 AccNo: 0001392380-25-000015 Size: 580 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 10-Q - Dare Bioscience, Inc. Filed: 2025-05-13 AccNo: 0001401914-25-000022 Size: 6 MB

New Form 10-Q - Quoin Pharmaceuticals, Ltd. Filed: 2025-05-13 AccNo: 0001410578-25-001226 Size: 4 MB

New Form 8-K - DYNAVAX TECHNOLOGIES CORP Filed: 2025-05-13 AccNo: 0001029142-25-000081 Size: 156 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

New Form 10-Q - HeartBeam, Inc. Filed: 2025-05-13 AccNo: 0001628280-25-025064 Size: 3 MB

Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2025 Financial Results and Recent Updates

NEXGEL Reports First Quarter 2025 Financial Results

Energous Wireless Power Solutions Reports First Quarter 2025 Results

OmniAb Showcases Innovative High-Throughput Single B-cell Screening xPloration® Platform at the 21st Annual PEGS Boston Summit

Seer Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook

Neogen Announces Board Transition with Appointment of Andrea Wainer and Retirement of James P. Tobin

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)